About Seborrheic Dermatitis
SD is a common skin condition (Primary Care Skin Forum 2016) that affects areas of the body with a particularly high concentration of sebaceous glands. This may include the eyebrows, bridge of the nose, nasolabial folds, ears and chest. It manifests as erythema, which progresses to flakiness and at its most severe, crusting of the skin. SD of the scalp is also particularly common, and in its mildest form may be referred to as dandruff. SD also often appears as cradle cap in infants. It usually clears by 12 months but can be a persistent problem during this time. The condition is also most common in middle age or older people. It may also be associated with those with a suppressed immune system, HIV and neurological conditions such as Parkinson's disease. At present there are various approaches to the management of SD but there is no `gold-standard' product.
Many of the treatments focus on the potential presence of fungi or other organisms on the surface of the skin, and topical corticosteroids are also frequently employed. Although topical corticosteroids are commonly used, they are also disliked, as this group of drugs may have unfavourable side effects, especially when used long-term or on sensitive areas of skin such as the face, hands, or on children. These effects vary from mild and reversible thinning, to irreversible telangiectasiae (fine blood vessels becoming visible at the surface of the skin), striae distensae (marks similar in appearance to `stretch marks') and Cushing syndrome (a round-shaped face, upper body weight gain, and skin that bruises easily). Steroids' effectiveness may also become less effective with continued use, which may lead to the escalation to a more potent steroid. There may also be a risk of growth suppression and adrenal suppression in children with the use of topical steroids.
About Sebclair ™
Sebclair ™ cream is the No. 1 treatment for seborrheic dermatitis in the US, and it is now available in Malaysia. Sebclair ™ is indicated to manage and relieve the itching, burning, scaling and pain experienced with SD. It is a non-steroidal, barrier enhancing, mildly keratolytc composition of ingredients formulated to help normalise skin physiology which has been altered by SD and cradle cap in infants. Sebclair ™ helps relieve dry waxy skin by maintaining a moist skin environment, which is beneficial to the healing process. Sebclair ™ cream can be used to control inflammation and the build-up of scaling on the skin. It is easy-to-use, patients only need to apply three times a day on affected areas and gently massage into the skin. Sebclair ™ cream is available on prescription by doctors all over Malaysia. For your nearest clinic with Sebclair ™ cream, contact Menarini +603 7985 7000.
About Menarini Asia Pacific
Menarini Asia-Pacific, a member of Italy-based Menarini Group, is a leading biopharmaceutical company focused on delivering differentiated healthcare consumer and ethical brands across the region. It markets a wide range of branded pharmaceutical, biotechnology, medical devices and consumer brands. It has gained strengths in the fields of Dermatology, Primary Care, Specialty Care and Consumer Health, and is now also expanding into the fields of Mens Health, Cardiovascular and Allergy/Respiratory. Some of the blockbuster-brands in the field of Dermatology includes: Dermatix, Emtrix, GlyDerm,Papulex, Atopiclair and Sebclair. To learn more about Menarini Asia Pacific, visit menariniapac.
For product enquiries, please contact the please contact the Product Manager Dermatology (Ethical Segment), Mr Anthony Choong at +603 7985 7000 or firstname.lastname@example.org
For media enquiries, please contact Apple Heart Marketing, Mr Carlson Gan at +6016 695 2416 or email@example.com or Mrs Grace Kang-Ong at +6012 3887918 or firstname.lastname@example.org